Developing an appropriately supported CME-accredited programme in Europe

Figures & data

Figure 1. The Lupus Academy Consortium.

Table 1. Inaugural meeting programme learning objectives.

Following this meeting the delegates should be able to:

• Understand the genetic and cellular mechanisms involved in the pathogenesis of lupus.

• Discuss patient perspectives on the burden of lupus and how best to manage this burden and improve patient outcomes.

• Cite the recent evidence that affects the positioning of the various treatment options and describe the current and future treatment options available for SLE.

• Better understand the issues of cardiovascular, renal and cutaneous manifestations of lupus.

• Appreciate the risk factors for infection, especially with steroid use, and infection prevention measures including the steroid-sparing effects of hydroxychloroquine and biologics.

• Relate the risk factors associated with pregnancy in the SLE patient.

Figure 2. A. Delegates’ countries of origin. B. Delegates’ specialities.

Figure 3. Overview of feedback.